Drug Kinetics – News and Features

Xenogen is producing and characterizing lines of custom-produced bioluminescent animal models for Gene Logic.

Researchers from ARUP describe how drug metabolism associated genes were assessed in patients by using P450 assays.

The studies aim at increasing the bioavailability of several new chemical entities in the human body.

NCL will characterize DNT's STARBURST™ dendrimers as macromolecular dendrimer-based MRI contrast agents.

Under the terms of this agreement, Mochida will receive a multi-user license to Admensa Interactive.

Bio-Rad's KnowItAll Informatics System offers a complete suite of tools for the computer-based prediction of a potential drug's ADME/Tox profile.

The agreement provides Angiotech with immediate access to CombinatoRx's combination pharmaceutical compounds.

The Alliance targets on developing RNAi-based therapeutics against select gene targets in ophthalmic diseases.

This collaboration allows Elan to access Strand's technologies and achieve customized solutions for internal research programs.

After 11 years as The Society for Biomolecular Screening, members have voted and approved the new name “Society for Biomolecular Sciences.”